Gilgamesh Pharmaceuticals
New York, NY
Gilgamesh is a pioneering early-stage biotech developing novel compounds that build upon the benefits of classic psychedelics with improvements of other components such as safety, tolerability, duration, and efficacy. Mental health worldwide has reached epidemic proportions and novel treatments have not kept pace with the urgent need to treat depression, anxiety, drug addiction and many other devastating diseases. Our purpose is to accelerate treatments and fundamentally improve mental health.
gilgameshpharmaceutical.comCompany Details
Founded
- 2019
Employees
- Between 10 - 50 employees
Raised
- $82,559,840
Headquarters Location
- New York, NY
Public
- No
Acquired
- No
CEO
- Jonathan Sporn
Founders
- Mike CunninghamAndrew KruegelJeff WitkinDalibor SamesJonathan Sporn
Company Collections
These are collections Gilgamesh Pharmaceuticals is a part of. Click on the collection name to view similar companies.